MANIFOLD
Will an AI-designed drug get FDA approval by the end of 2025?
36
Ṁ1kṀ3.1k
resolved Jan 3
Resolved
NO

There are currently several AI-designed drugs in clinical trials, but no AI-designed drug has received FDA approval thus far (see https://www.nature.com/articles/s41591-023-02361-0).

This market resolves to YES iff a drug where a signifcant portion of the design was carried out by non-human agents (so not a repurposed drug, but not necessarily a fully generative AI-designed drug either) gains FDA approval by EOY 2025.

Market context
Technology
AI
Technical AI Timelines
Science
Biotech
Get
Ṁ1,000
to start trading!

🏅 Top traders

#TraderTotal profit
1Ṁ158
2Ṁ71
3Ṁ55
4Ṁ40
5Ṁ39

People are also trading

How many AI-generated drugs will be approved by the FDA by the end of 2030?
16
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
55% chance
Will AI developed molecules or drugs be the dominant sources of new biopharma IP by Sep 5 2029?
74% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
27% chance
Will a regulatory body modeled on the FDA regulate AI in the US by the end of 2027?
16% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
72% chance
Will an AI be able to write a prescription for medication in the US or a EU member country by 2030?
15% chance
Will FDA approve an “AI doctor” for primary care before 2030?
31% chance
Will it be possible to obtain FDA approval for a drug based on protein folding stimulations without human clinical trials by 2035?
9% chance
By 2035, will the FDA approve a drug that slows the yearly progression of Alzheimer's disease by at least 50%?
57% chance
Sort by:

https://x.com/andrewcurran_/status/1881700091179979086?s=61

What counts as AI designed? Many researchers are already using some aspect of AI/ML in their research. My guess is even if the drug was designed purely by an algorithm the researcher would still claim it was them.

There is an article cautioning against unbridled exuberance in Nature News 22nd September by the same writer

"by 2025" and "closes 2026" are contradictory, might want to edit it one way or the other.

@Tasty_Y Huh it says closes 2025 for me… maybe I can rephrase it to “by the end of 2025?”

predictedNO

@AazerSiddiqui Well, that would be consistent then.

People are also trading

How many AI-generated drugs will be approved by the FDA by the end of 2030?
16
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
55% chance
Will AI developed molecules or drugs be the dominant sources of new biopharma IP by Sep 5 2029?
74% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
27% chance
Will a regulatory body modeled on the FDA regulate AI in the US by the end of 2027?
16% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
72% chance
Will an AI be able to write a prescription for medication in the US or a EU member country by 2030?
15% chance
Will FDA approve an “AI doctor” for primary care before 2030?
31% chance
Will it be possible to obtain FDA approval for a drug based on protein folding stimulations without human clinical trials by 2035?
9% chance
By 2035, will the FDA approve a drug that slows the yearly progression of Alzheimer's disease by at least 50%?
57% chance
© Manifold Markets, Inc.•Terms•Privacy